The loss of RBP ZFP36 function leads to ARE-mRNA stabilization in a variety of human cancers such as prostate cancer, pancreatic cancer, breast cancer, colorectal cancer, malignant melanoma, hepatocellular carcinoma (HCC), malignant glioma, and lung cancer [22]. This evidence concerns the gene ZFP36 and prostate carcinoma.